Instituto de Investigación Biotecnológica, Farmacéutica y Medicamentos Huérfanos, S.L.
ES-MF-000001065 · Spain · Granada
Instituto de Investigación Biotecnológica, Farmacéutica y Medicamentos Huérfanos, S.L. is registered in the European database on medical devices as a manufacturer, with 8 devices declared. It was not found in the U.S. FDA device establishment register.
What this manufacturer declares
| Class I | 7 |
|---|---|
| Class IIa | 1 |
Most frequent device types declared: Dermcontrol, HAMD 2, HAMD 3, HAMD1, HAMD4.
Among these devices, 7 are declared sterile, 7 implantable.
Devices declared under this manufacturer
- Inveskin Dermcontrol 75 mL
- Wiotech HA MD aqua 20 mg/mL hydration & fine lines
- Wiotech HA MD double 20 mg/mL volume&lines
- Wiotech HA MD double 20,5 mg/mL volume&lines
- Wiotech HA MD high 13 mg/mL volume&lines
- Wiotech HA MD high 15 mg/mL volume&lines
- Wiotech HA MD high 17 mg/mL volume&lines
- Wiotech HA MD medium 20 mg/mL volume&lines
Catalogue references include HAMD1, HAMD2, HAMD3, HAMD4, HAMD5, HAMD6.
European nomenclature codes declared: P900402, M9002.
United States market access
| FDA establishment register | Not found in the FDA register |
|---|---|
| Devices in EUDAMED | 8 |
| Country of registration | Spain |
⚠️ Not found is not the same as not sold — how this comparison can be wrong.
Canadian market access
| Health Canada licence listing | Not found in the Canadian register |
|---|
⚠️ Canada lists no Class I devices at all — what that excludes.
North American profile: Neither register. Instituto de Investigación Biotecnológica, Farmacéutica y Medicamentos Huérfanos, S.L. was not found in either the U.S. or the Canadian register.